Immunotherapy
-
Researchers have found that administering under-the-tongue immunotherapy given to young peanut-allergic children is a safe and effective way of desensitizing them to the food. It may provide another method of curbing this potentially deadly allergy.
-
Each year, more than 150,000 Americans are diagnosed with bowel cancer, or colorectal cancer, and the disease has a dire survival rate if surgery isn’t successful. Scientists now believe they have found one tiny molecule that could change all that.
-
Around 1.6 million Americans live with inflammatory bowel disease, dealing with persistent and debilitating relapses. Scientists have identified how a specialized subset of T cells falter in flare-ups, and they may hold they key to long-term recovery.
-
Scientists have discovered an unknown type of immune cell in people who've successfully beat cancer. These home in on multiple targets at once, preventing new tumors forming for up to a year later and could lead to more effective cancer therapies.
-
A phase 1 clinical trial exploring the use of fecal transplants to supplement immunotherapy treatment for melanoma has found it to be safe and has the potential to improve patients’ response to treatment.
-
New research has discovered that a fundamental nutrient found in cells is key to maintaining the body’s cancer-destroying immune response. The discovery may lead to more effective ways of treating the disease.
-
A chemo and immunotherapy combo has proven promising in treating patients with advanced Hodgkin Lymphoma, and removes the need for radiation therapy in kids. In a clinical trial, 94% of patients receiving the combo treatment entered remission.
-
A Phase 3 clinical trial of the drug donanemab has shown it can significantly slow cognitive and functional decline in people with early-stage Alzheimer’s disease, compared with existing treatments.
-
Constantly fighting cancer or other diseases can exhaust our immune system’s T cells. A new study has identified a way of reviving exhausted T cells so they’re ready to fight again, improving the effectiveness of cancer immunotherapy.
-
In new hope for aggressive brain cancers, injecting a drug-laden hydrogel into the brain after tumors were surgically removed was found to launch a combined chemo- and immunotherapy attack, preventing cancer from returning in 100% of treated mice.
-
That a new cancer trial is about to start in the US is positive but not out of the ordinary, right? Except it is. This trial will be one of the first undertaken in a real-world clinical setting and represents a new model for future clinical trials.
-
Cancer cells are notorious for evading detection by the immune system. But a promising new type of genetically engineered T-cell that can effectively destroy solid cancer tumors may be just what the doctor ordered.
Load More